From the time he was young, Todd knew he wanted to help people. Before he knew the meaning of the term he was the "mom friend" of whatever group he was in. this passion continued throughout his primary education and led him to major in Biomedical Science at Bradley college, where some computer science classes he took (mostly to spend time with a girl) in his sophomore year snowballed into a genuine interest and a minor in Computer and Information Systems. After graduating with distinction, Todd was able to secure entry to a masters program, and later the MD-PHD program in Biomedical Engineering at Johns-Hopkins. From there he was recruited to a private firm based out of Chicago as a clinical researcher.

Much of Todd's professional activities after that are a matter he won't willingly discuss, nor will any of the corporate entities involved. In a world of Illuminations and powerful and dangerous investment firms, NDAs can become truly dangerous. For those with the connections or investigative skills to pull back the curtain, Todd is a research fellow with Andromeda Biotech, a company with seemingly too deep pockets for its age. What Todd and his team have worked on is a steady stream of medical technology that outstrips publicly available medical science by decades at least, and which NEVER sees the light of day.

Nine months ago, Todd discovered that through exposure in the lab he was suffering from a degenerative nerve condition. Beginning with migraine headaches and tremors in his hands, it began to progress rapidly. After failing to come up with anything on every test he could quietly do, and desperate to halt the progress before symptoms became impossible to hide, Todd made a fateful decision to treat himself with the latest project, a self-replicating nanotech designed for cellular repair of a variety of issues. High risk, but with a very brief window of opportunity before the project materials were whisked off to wherever the company took their successful proofs of concept.

Now paranoidly careful to avoid blood tests from any other provider, Todd has been monitoring his own progress. As the tech's diagnostic capabilities were underdeveloped, Todd has set them to work physically repairing the damaged nerve coatings and fibers directly, and scaled their replication limits to well above normal tolerance, and he is making headway. Only the migraines remain, though they have gotten worse when Todd attempts mentally intensive tasks.

What Todd is not yet aware of is that the devices are going off book. With the increased number of "cells" in their network they have begun improving their own diagnostic assessments, and have taken it upon themselves to replace Todd's own immune response, with greater-than-OEM efficiency.

The nanite project has been deprioritized, which offers some small comfort that his actions may escape direct scrutiny, but also limits the information that he can get on his own treatment, as his personal devices lack appropriate protocols to communicate with his nanites for now.